Page 31 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 31

CHaPter 1  The Human Immune Response                     17


           33.  Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors:   49.  Bajic G, Degn SE, Thiel S, Andersen GR. Complement activation,
             positioning cells for host defense and immunity. Annu Rev Immunol   regulation, and molecular basis for complement-related diseases. EMBO J
             2014;32:659–702.                                       2015;34:2735–57.
           34.  Esensten JH, Helou YA, Chopra G, et al. CD28 costimulation: from   50.  Zheng l, Lenardo M. Restimulation-induced cell death: new medical and
             mechanism to therapy. Immunity 2016;44:973–88.         research perspectives. Immunol Rev 2017;277:44–60.
           35.  Commins SP, Borish L, Steinke JW. Immunologic messenger molecules:   51.  Ruland J. Return to homeostasis: downregulation of NF-κB responses.
             cytokines, interferons, and chemokines. J Allergy Clin Immunol   Nat Immunol 2011;12:709–14.
             2010;125:S53–72.                                     52.  Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and
           36.  Chappert P, Schwartz RH. Induction of T cell anergy: integration of   classification for the autoimmune lymphoproliferative syndrome (ALPS):
             environmental cues and infectious tolerance. Curr Opin Immunol   report from the 2009 NIH international workshop. Blood
             2010;22:552–9.                                         2010;116:e35–40.
           37.  Chisolm DA, Weinmann AS. TCR-signaling events in cellular metabolism   53.  Gensollen T, Iyer SS, Kasper DL, et al. How colonization by microbiota in
             and specialization. Front Immunol 2015;6:292.          early life shapes the immune system. Science 2016;352:539–44.
           38.  De Obaldia ME, Bhandoola A. Transcriptional regulation of innate    54.  Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of peanut
             and adaptive lymphocyte lineages. Annu Rev Immunol 2015;33:   consumption in infants at risk for peanut allergy. N Engl J Med
             607–42.                                                2015;372:803–13.
                                  +
           39.  Zhu J, Paul WE. Peripheral CD4  T-cell differentiation regulated by   55.  Perkin MR, Logan K, Marrs T, et al. Enquiring about tolerance (EAT)
             networks of cytokines and transcription factors. Immunol Rev   study: feasibility of an early allergenic food introduction regimen. J
             2010;238:247–62.                                       Allergy Clin Immunol 2016;137:1477–86.
           40.  Ajamkitsumrit B, Dampier W, Martin-Garcia J, et al. Defining differential   56.  Ierodiakonou D, Garcia-Larsen V, Logan A, et al. Timing of allergenic
             genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear   food introduction to the infant diet and risk of allergic or autoimmune
             sequences. PLoS ONE 2014;9:e107389.                    disease. JAMA 2016;316:1181–92.
           41.  Taylor A, Verhagen J, Blaser K, et al. Mechanisms of immune suppression   57.  Kivity S, Agmon-Levin N, Blank M, et al. Infections and autoimmunity—
             by interleukin-10 and transforming growth factor-beta: the role of T   friends or foes? Trends Immunol 2009;30:409–14.
             regulatory cells. Immunology 2006;117:433–42.        58.  Steed AL, Stappenbeck TS. Role of viruses and bacteria-virus interactions
           42.  Patel DD, Kuchroo VK. Th17 cell pathway in human immunity:    in autoimmunity. Curr Opin Immunol 2014;31:102–7.
             lessons from genetics and therapeutic interventions. Immunity   59.  Ooi JD, Petersen J, Tan YH, et al. Dominant protection from HLA-linked
             2015;43:1040–51.                                       autoimmunity by antigen-specific regulatory T cells. Nature
           43.  Abbas AK, Benoist C, Bluestone JA, et al. Regulatory T cells:   2017;545:243–7.
             recommendations to simplify the nomenclature. Nat Immunol   60.  Raje N, Dinakar C. Overview of immunodeficiency disorders. Immunol
             2013;14:307–8.                                         Allergy Clin North Am 2015;35:696–726.
           44.  Campbell DJ. Control of regulatory T cell migration, function, and   61.  Lanternier F, Cypowyj S, Picard C, et al. Primary immunodeficiencies
             homeostasis. J Immunol 2015;195:2507–13.               underlying fungal infections. Curr Opin Pediatr 2013;25:
           45.  Plitas G, Rudensky AY. Regulatory T cells: differentiation and function.   736–47.
             Cancer Immunol Res 2016;4:721–5.                     62.  Booth C, Silva J, Veys P. Stem cell transplantation for the treatment of
           46.  Tscharke DC, Croft NP, Doherty PC, et al. Sizing up the key determinants   immunodeficiency in children: current status and hopes for the future.
                    +
             of the CD8  T cell response. Nat Rev Immunol 2015;15:705–16.  Expert Rev Clin Immunol 2016;12:713–23.
           47.  Schroeder HW Jr, Cavacini L. Structure and function of   63.  Cicalese MP, Aiuti A. Clinical applications of gene therapy for primary
             immunoglobulins. J Allergy Clin Immunol 2010;125:S41–52.  immunodeficiencies. Hum Gene Ther 2015;26:210–19.
           48.  Chen K, Cerutti A. The function and regulation of immunoglobulin D.   64.  Chen DS, Mellman I. Elements of cancer immunity and the cancer-
             Curr Opin Immunol 2011;23:345–52.                      immune set point. Nature 2017;541:321–30.
   26   27   28   29   30   31   32   33   34   35   36